91 related articles for article (PubMed ID: 29047108)
1. DLBCL arising from indolent lymphomas: How are they different?
Parry EM; Roulland S; Okosun J
Semin Hematol; 2023 Nov; 60(5):277-284. PubMed ID: 38072721
[TBL] [Abstract][Full Text] [Related]
2. Characterization of primary small intestinal lymphoma: a retrospective study based on double balloon endoscopy.
Li L; Ma H; Niu M; Chen C; Yu C; Zhang H; Jin M
BMC Gastroenterol; 2024 Mar; 24(1):116. PubMed ID: 38504190
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Hjorth MK; Kamstrup MR
Ugeskr Laeger; 2024 Feb; 186(9):. PubMed ID: 38445325
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
Kumada H; Watanabe T; Suzuki F; Ikeda K; Sato K; Toyoda H; Atsukawa M; Ido A; Takaki A; Enomoto N; Kato K; Alves K; Burroughs M; Redman R; Pugatch D; Pilot-Matias TJ; Krishnan P; Oberoi RK; Xie W; Chayama K
J Gastroenterol; 2018 Apr; 53(4):566-575. PubMed ID: 29052790
[TBL] [Abstract][Full Text] [Related]
5. Understanding lymphoma molecular complexity.
Pileri SA
Blood; 2017 Oct; 130(16):1780-1781. PubMed ID: 29051151
[No Abstract] [Full Text] [Related]
6. The cost-effectiveness of immediate treatment or watch and wait with deferred chemotherapy for advanced asymptomatic follicular lymphoma.
Prettyjohns M; Hoskin P; McNamara C; Linch D;
Br J Haematol; 2018 Jan; 180(1):52-59. PubMed ID: 29076139
[TBL] [Abstract][Full Text] [Related]
7. Lifetime alcohol intake and risk of non-Hodgkin lymphoma: Findings from the Melbourne Collaborative Cohort Study.
Jayasekara H; Juneja S; Hodge AM; Room R; Milne RL; Hopper JL; English DR; Giles GG; MacInnis RJ
Int J Cancer; 2018 Mar; 142(5):919-926. PubMed ID: 29055104
[TBL] [Abstract][Full Text] [Related]
8. Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia.
Younossi ZM; Chan HLY; Dan YY; Lee MH; Lim YS; Kruger E; Tan SC
J Viral Hepat; 2018 Mar; 25(3):228-235. PubMed ID: 29053909
[TBL] [Abstract][Full Text] [Related]
9. Genomic analysis of adult Burkitt lymphoma.
Blood; 2017 Oct; 130(16):1871. PubMed ID: 29051155
[No Abstract] [Full Text] [Related]
10. Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma.
Fu L; Yu J; Chen Z; Gao F; Zhang Z; Fu J; Feng W; Hong P; Jin J
Infect Agent Cancer; 2024 Apr; 19(1):15. PubMed ID: 38654358
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities.
Rosenberg M; Poluch M; Thomas C; Sindaco P; Khoo A; Porcu P
Front Oncol; 2023; 13():1275800. PubMed ID: 37927464
[TBL] [Abstract][Full Text] [Related]
12. Extranodal Diffuse Large B-Cell Lymphoma of Bone and Soft Tissue Presenting With Marked Lymphedema and Hypercalcemia.
Shabbir A; Kojadinovic A; Gidfar S; Mundi PS
Cureus; 2022 Feb; 14(2):e22025. PubMed ID: 35155052
[TBL] [Abstract][Full Text] [Related]
13. Relevance on the diagnosis of malignant lymphoma of the salivary gland.
Zhang XY; Wang ZM
World J Clin Cases; 2020 Jul; 8(13):2717-2726. PubMed ID: 32742982
[TBL] [Abstract][Full Text] [Related]
14. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
Merli M; Frigeni M; Alric L; Visco C; Besson C; Mannelli L; Di Rocco A; Ferrari A; Farina L; Pirisi M; Piazza F; Loustaud-Ratti V; Arcari A; Marino D; Sica A; Goldaniga M; Rusconi C; Gentile M; Cencini E; Benanti F; Rumi MG; Ferretti VV; Grossi P; Gotti M; Sciarra R; Tisi MC; Cano I; Zuccaro V; Passamonti F; Arcaini L
Oncologist; 2019 Aug; 24(8):e720-e729. PubMed ID: 30552159
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.
Hosry J; Miranda RN; Samaniego F; Economides MP; Torres HA
Int J Cancer; 2018 Mar; 142(5):940-948. PubMed ID: 29047108
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.
Hosry J; Mahale P; Turturro F; Miranda RN; Economides MP; Granwehr BP; Torres HA
Int J Cancer; 2016 Dec; 139(11):2519-28. PubMed ID: 27501007
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.
Visco C; Finotto S
World J Gastroenterol; 2014 Aug; 20(32):11054-61. PubMed ID: 25170194
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patients.
Hosry J; Miranda RN; Samaniego F; Angelidakis G; Torres HA
Hematol Oncol; 2020 Aug; 38(3):301-308. PubMed ID: 32196714
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
